Calgary, Alberta–(Newsfile Corp. – January 22, 2021) – Hemostemix Inc. (TSXV: HEM) (OTC: HMTXD) (“Hemostemix” or the “Enterprise“) is pleased to announce it has signed the Building Relationships Business people & Dealmakers (BREAD) agreement with the Section of Overseas Affairs, Trade and Progress. An initiative to guide substantial-opportunity, biotech concentrated Canadian Smaller and Medium Company (SMEs), the plan is designed to accelerate the expansion of Hemostemix and other Canadian biotechnology businesses.
“We are actively working with the Trade Commissioner Support of CANADA in the United states of america, Japan and South Korea to resource experienced associates to go to market with,” mentioned Thomas Smeenk, CEO. “The BREAD arrangement marks our Firm’s starting off place to out-license ACP-01, and it generates our sponsorship into BioCom.”
ABOUT THE TRADE COMMISSIONER Service OF CANADA
The Trade Commissioner Service (TCS) plays an active role in serving to Canadian businesses obtain